abstract |
The present invention provides a labelled beta -amyloid peptide or a labelled active fragment of beta -amyloid peptide and methods of using the labelled peptides to screen for agents which affect the deposition of the labelled peptide onto amyloid plaques in tissue samples evidencing the presence of Alzheimer's amyloidosis. |